“As with much of the medical device and wound care industry, Q1 tends to be a seasonally softer quarter for SANUWAVE, but the underlying strength of our business has led to a smaller seasonal effect than that seen in recent years,” said CEO Morgan Frank. “This was the highest Q1 revenue in Company history by a wide margin, and the second best revenue quarter in Company history behind only Q4 2023. We’re excited to report year-on-year revenue growth in excess of 50% for the quarter, a significant acceleration in growth versus prior quarters. The Company plans to release its full Q1 results in mid-May, and we look forward to speaking with you then to give you a more complete update on our quarterly performance and our future plans and guidance.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNWV:
- Sanuwave Health Announces CFO Transition and New Financial Strategy
- SANUWAVE Health Appoints Industry Veteran Peter Sorensen as Chief Financial Officer
- SANUWAVE Will Host a Conference Call on March 22, 2024 at 8:30 AM (ET) to Present the Q4 and FY2023 Financial Results
- SANUWAVE Health Reports Stockholder Approval of SEPA Merger at Special Meeting of Stockholders
- Sanuwave Health Shareholders Approve Transformational Merger
